Skip to main content

Want a detailed portfolio tracker?

ProKidney (PROK) P/E (2023 - 2026)

ProKidney (PROK) P/E from Jan 3, 2023 to Jul 21, 2026. The TTM ProKidney (PROK) P/E is -0.66. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of ProKidney (PROK)

YearP/EChange
2026-0.66-28.79%
2025-0.93+32.54%
2024-0.70-5.06%
2023-0.74N/A

Comparison ProKidney (PROK) P/E with competitors

ProKidney (PROK) P/E is -0.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.26%
NBYStablecoin Development Corp0.00-100.65%
ENLVEnlivex Ltd0.07-111.29%
FGENFibroGen Inc0.24-136.22%
CHRSCoherus Biosciences Inc0.85-228.05%
FBIOFortress Biotech Inc0.95-243.22%
ORMPOramed Pharmaceuticals Inc1.50-326.82%
AGENAgenus Inc3.01-554.17%
INVAInnoviva Inc3.15-575.96%
VXRTVaxart Inc3.55-635.68%
CRMDCorMedix Inc3.63-647.55%
CVACCureVac N.V.4.45-770.88%
GLPGGalapagos NV4.86-833.24%
SRPTSarepta Therapeutics Inc4.88-836.74%
ABEOAbeona Therapeutics Inc5.39-913.01%
ABUSArbutus Biopharma Corp5.60-944.41%
ZVRAZevra Therapeutics Inc5.89-988.42%
SPROSpero Therapeutics Inc6.23-1039.91%
CGENCompugen Ltd6.31-1052.81%
RIGLRigel Pharmaceuticals6.87-1137.04%
SLXNSilexion Therapeutics Corp7.30-1201.02%
OMEROmeros Corporation9.26-1497.20%
AUPHAurinia Pharmaceuticals Inc9.58-1546.43%
PLXProtalix BioTherapeutics Inc10.89-1743.52%
ACADAcadia Pharmaceuticals Inc11.73-1869.91%
TBPHTheravance Biopharma Inc12.26-1950.44%
ADMAAdma Biologics Inc12.42-1973.98%
HRMYHarmony Biosciences Holdings Inc13.82-2185.56%
SABSSAB Biotherapeutics Inc14.14-2233.24%
NAGENiagen Bioscience Inc14.82-2336.15%
INCYIncyte Corp15.82-2487.73%
REGNRegeneron Pharmaceuticals Inc15.86-2492.87%
PBYIPuma Biotechnology Inc17.32-2713.05%
CPRXCatalyst Pharmaceuticals Inc17.44-2731.71%
EXELExelixis Inc17.54-2746.60%
TGTXTG Therapeutics Inc18.97-2962.10%
MDXGMimedx Group Inc20.55-3201.51%
XOMAXOMA Royalty Corp22.87-3552.03%
ARGXArgen X SE24.30-3766.82%
CTMXCytomX Therapeutics Inc24.82-3845.77%
XOMAOXOMA Royalty Corp25.34-3924.80%
HALOHalozyme Therapeutics Inc25.62-3966.89%
XOMAPXOMA Royalty Corp25.67-3973.89%
VRTXVertex Pharmaceuticals Inc27.99-4324.70%
RPRXRoyalty Pharma plc - Class A28.69-4429.25%
SLNOSoleno Therapeutics Inc29.02-4478.72%
ASNDAscendis Pharma A/S30.09-4640.23%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5821.32%
APLSApellis Pharmaceuticals Inc39.02-5988.71%
BMRNBiomarin Pharmaceutical Inc42.21-6470.21%
KRYSKrystal Biotech Inc45.34-6942.81%
ONCBeiGene Ltd69.54-10594.39%
PHARPharming Group N.V.75.03-11422.16%
TECHBio-Techne Corp101.96-15486.61%
VCELVericel Corp109.92-16688.30%
ALNYAlnylam Pharmaceuticals Inc117.96-17902.19%
GMABGenmab140.29-21271.37%
TLXTelix Pharmaceuticals Ltd162.15-24570.59%
CORTCorcept Therapeutics Inc212.86-32222.47%